Researcher Profile Statistics: van Roon-Mom, Willeke
Geo Map
Region
#
NA - North America
89
EU - Europe
71
AS - Asia, other
15
Unknown
5
Total
180
Country
#
DE - Germany
52
US - United States of America
51
CA - Canada
38
FR - France
11
CN - China
9
IE - Ireland
3
IL - Israel
3
SG - Singapore
2
CZ - Czech Republic
1
ES - Spain
1
other - Other Country
9
Total
180
City
#
Toronto
38
Strasbourg
11
Ashburn
9
Shanghai
9
Des Moines
6
Leipzig
6
Hanover
5
Siegen
5
Atlanta
4
Hechingen
4
other
83
Total
180
Most viewed items
#
ID: 1921 - The MID1 protein: a promising therapeutic target in Huntington’s disease
180
Total
180
Most type viewed
#
ID: all -
180
ID: other -
0
ID: journal -
180
ID: conference -
0
ID: book -
0
ID: thesis -
0
ID: selected -
0
Total
360
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2022
0 0
0 0 0 16
18 5 2 13
0 18
72
2023
2 4
4 8 6 1
7 2 1 0
4 7
46
2024
11 3
2 46 0 0
0 0 0 0
0 0
62
Ever
180
Geo Map
Region | # |
---|---|
NA - North America | 89 |
EU - Europe | 71 |
AS - Asia, other | 15 |
Unknown | 5 |
Total | 180 |
Country | # |
---|---|
DE - Germany | 52 |
US - United States of America | 51 |
CA - Canada | 38 |
FR - France | 11 |
CN - China | 9 |
IE - Ireland | 3 |
IL - Israel | 3 |
SG - Singapore | 2 |
CZ - Czech Republic | 1 |
ES - Spain | 1 |
other - Other Country | 9 |
Total | 180 |
City | # |
---|---|
Toronto | 38 |
Strasbourg | 11 |
Ashburn | 9 |
Shanghai | 9 |
Des Moines | 6 |
Leipzig | 6 |
Hanover | 5 |
Siegen | 5 |
Atlanta | 4 |
Hechingen | 4 |
other | 83 |
Total | 180 |
Most viewed items | # |
---|---|
ID: 1921 - The MID1 protein: a promising therapeutic target in Huntington’s disease | 180 |
Total | 180 |
Most type viewed | # |
---|---|
ID: all - | 180 |
ID: other - | 0 |
ID: journal - | 180 |
ID: conference - | 0 |
ID: book - | 0 |
ID: thesis - | 0 |
ID: selected - | 0 |
Total | 360 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | 0 | 0 | 0 | 0 | 0 | 16 | 18 | 5 | 2 | 13 | 0 | 18 | 72 |
2023 | 2 | 4 | 4 | 8 | 6 | 1 | 7 | 2 | 1 | 0 | 4 | 7 | 46 |
2024 | 11 | 3 | 2 | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 62 |
Ever | 180 |